Research and News Involving:
Oncology
Adult, Chicago, Clinical Trials, Dr. Liotta, Edward Hines Jr. VA Hospital and CARES, Loyola University Medical Center, Military/Veteran, Neuro, Northwestern University, Oncology, Rare Disease, Shirley Ryan AbilityLab, Women's Health
Press Release: Finalists Announced for CureAccelerator Live! for Chicago 2020 Competition Finalists Announced for CureAccelerator Live! for Chicago 2020 Competition Virtual Pitch Event on September 15 Features 4 Clinical Repurposing Projects from Chicago Region July...
Clinical Trials, Dr. Faustman, Massachusetts General Hospital, Neuro, Oncology, Patient Impact Awards
Press Release: Cures Within Reach Names Three Recipients of the 2019 Global Health Repurposing Awards Cures Within Reach Names Three Recipients of the 2019 Global Health Repurposing Awards Honorees Alzheimer’s Drug Discovery Foundation, Denise Faustman, MD, PhD,...
Adult, Clinical Trials, Developing World, Dr. Chang, Dr. Mehta, Dr. Osman, Drug, Infectious Disease, LMICs, Oncology, Openbiome, Pediatric, SIDS Hospital and Research Centre, Underrepresented
Press Release: Finalists Announced for CureAccelerator Live! Competition, Impacting Patients in Developing World Finalists Announced for CureAccelerator Live! Competition, Impacting Patients in Developing World Pitch Event on May 23 in Boston Features 5 Medical...
Adult, Current Research, Developing World, Dr. Malichewe, Drug, LMICs, Muhimbili University Health and Allied Sciences, Oncology, Rare Disease, ReGRoW, Underrepresented
Testing a Generic Drug Combination to Treat AML in Tanzania Principal Investigator: Dr. Christina Malichewe Disease: Acute Myeloid Leukemia Research Description: Acute myeloid leukemia (AML) is a blood cancer that is difficult to manage, and patients may have shorter...
Adult, Chicago, Current Research, Dr. Reizine, Health Disparities, Nutraceutical, Oncology, Underrepresented, University of Illinois at Chicago
Glycyrrhizin in Prostate Cancer: A Window-of-Opportunity Clinical Trial Principal Investigator: Dr. Natalie Reizine Disease: Prostate Cancer Research Description: Prostate cancer (PC) is the second most common cause of cancer-related death in American men, and...
Colorado State University, Current Research, Dr. Regan, Drug, Oncology, Pre-clinical, Rare Disease
Evaluating an Approved Drug Combination Plus Immunotherapy in Canine Metastatic Osteosarcoma Principal Investigator: Dr. Daniel Regan Disease: Canine Metastatic Osteosarcoma Research Description: Metastasis remains the greatest challenge in osteosarcoma (OS) patient...
Adult, Current Research, Dr. Ghosh, Drug, Oncology, Rare Disease, University of Michigan
Reducing CAR T-cell Therapy Complications in Relapsed Lymphoma Patients by Adding Natalizumab Principal Investigator: Dr. Monalisa Ghosh Disease: Relapsed Lymphoma Research Description: Chimeric antigen receptor (CAR) T-cell therapy offers new hope through...
Adult, Chicago, Current Research, Dr. Ibraheem, Drug, Oncology, Underrepresented, University of Illinois at Chicago, Women's Health
Using a Generic Drug Combination in Early-Stage Hormone Receptor Positive Breast Cancer Patients Principal Investigator: Dr. Abiola Ibraheem Disease: Breast Cancer Research Description: Preferred chemotherapy treatments for early-stage breast cancer are often...
Adult, Brigham Young University, Current Research, Dr. Watt, Drug, Oncology, Rare Disease
Treating Anemia in Myelofibrosis with Nelfinavir Principal Investigator: Dr. Richard Watt Disease: Myelofibrosis Research Description: Patients with myelofibrosis, an incurable blood cancer, often have chronic inflammation, which results in high levels of the hormone...
Adult, City of Hope, Current Research, Dr. Phillips, Drug, Los Angeles, Oncology, Rare Disease, Underrepresented
Repurposing Venetoclax and Glofitamab to Improve Patient Response in Mantle Cell Lymphoma Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is...
Adult, Current Research, Dr. Romancik, Drug, Emory University, Oncology, Rare Disease
Combining Approved Drugs for Alcoholism and Cancer to Treat Diffuse Large B-cell Lymphoma Principal Investigator: Dr. Jason Romancik Disease: Diffuse Large B-cell Lymphoma Research Description: Diffuse large B-cell lymphoma (DLBCL) and other aggressive subtypes of...
Brown University, CureAccelerator Live!, Current Research, Dr. Holder, Drug, Oncology, Rare Disease, Rhode Island Hospital, Underrepresented
Repurposing the Prostate Cancer Drug Degarelix to Treat Bladder Cancer Principal Investigator: Dr. Sheldon Holder Condition: Bladder Cancer Research Description: More than 80,000 people are diagnosed with bladder cancer (BC) in the USA each year and roughly 17,000...
Adult, Completed Research, Dr. Ito, Drug, Oncology, Rare Disease, University of Pittsburgh
Investigating a Rare Disease Drug to Treat AML and MDS Patients with Post-Stem Cell Transplant Relapse Principal Investigator: Dr. Sawa Ito Disease: Acute Myeloid Leukemia and Myelodysplastic Syndrome Research Description: Allogeneic hematopoietic stem cell...
Current Research, Dr. Ohanian, Drug, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center
Adding Metal Detoxification Drugs to Improve Childhood AML and Other Blood Cancer Outcomes Principal Investigator: Dr. Maro Ohanian Disease: Pediatric, adolescent and young adult Acute Myeloid Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia...
Adult, Chicago, Completed Research, Device, Diagnostic, Dr. Sims, Health Disparities, Oncology, Rare Disease, Underrepresented, University of Illinois at Chicago
Repurposing a Diagnostic Device to Address Health Disparities in Esophageal Cancer Screening and Outcomes Principal Investigator: Dr. H. Steven Sims Disease: Esophageal cancer Research Description: Esophageal cancer can be divided into two types: adenocarcinoma (the...
Adult, Current Research, Developing World, Dr. Ntekim, Drug, LMICs, Oncology, Rare Disease, ReGRoW, Underrepresented, University College Hospital Ibadan, Women's Health
Adding the Antibiotic Clofazimine to Chemotherapy for Triple Negative Breast Cancer in Nigeria Principal Investigator: Dr. Atara Ntekim Disease: Breast cancer Research Description: Breast cancer causes high cancer related death globally. A type called triple negative...
CureAccelerator Live!, Current Research, Dr. Gordon, Drug, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center, Underrepresented
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
Adult, Chicago, CureAccelerator Live!, Current Research, Drug, Loyola University Medical Center, Oncology, Rare Disease, Women's Health
Repurposing the Blood Pressure Drug Minoxidil for the Treatment of Recurrent Chemo-Resistant Ovarian and Other Gynecological Cancers Principal Investigator: Dr. Margaret Liotta Disease: Ovarian cancer Research Description: Epithelial ovarian cancer is the most lethal...
Combo, Drug, Oncology, Pre-clinical, Prof. Allen, Rare Disease, University of Cambridge
Testing two generic drugs to improve outcomes in osteosarcoma, a rare bone cancer Principal Investigator: Prof. Matthew Allen Disease: Osteosarcoma Research Description: Although osteosarcoma (OSA) is a rare type of cancer, it is the most common bone cancer in...
Adult, CureAccelerator Live!, Dr. Phillips, Drug, Oncology, Rare Disease, Underrepresented, University of Michigan
Improving Patient Response in Mantle Cell Lymphoma with Venetoclax Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is diagnosed mostly in older...
